Medical device maker Medtronic plc (NYSE: MDT) reported a decline in adjusted earnings for the second quarter of 2024, despite an increase in revenues.
Second-quarter earnings, adjusted for special items, dropped 4% annually to $1.25 per share. Meanwhile, unadjusted net profit more than doubled to $909 million or $0.68 per share during the three-month period.
All four operating segments expanded in the October quarter, driving up total revenues to about $8 billion. The management expects organic revenue to grow 4.75% in fiscal 2024.
The post Medtronic (MDT) Q2 2024 adj. earnings decline despite revenue growth first appeared on AlphaStreet.
Blog powered by G6
Disclaimer! A guest author has made this post. G6 has not checked the post. its content and attachments and under no circumstances will G6 be held responsible or liable in any way for any claims, damages, losses, expenses, costs or liabilities whatsoever (including, without limitation, any direct or indirect damages for loss of profits, business interruption or loss of information) resulting or arising directly or indirectly from your use of or inability to use this website or any websites linked to it, or from your reliance on the information and material on this website, even if the G6 has been advised of the possibility of such damages in advance.
For any inquiries, please contact [email protected]